Diabetes patients in the community

prevalence and medication adherence among diabetes patients in the community a prospective observational study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/10/010117

Enrollment

108

Registered

2017-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic Patients

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diabetes of any age group 2.Diabetes patients having any co-morbid condition 3.Patients of either of any gender (Male and Female) 4.Patients who are capable to giving written consent form

Exclusion criteria

Exclusion criteria: • Patients who are not willing to participate. • Pregnant and lactating women. • Patients who are unconscious, Semi â?? conscious and disoriented.

Design outcomes

Primary

Measure	Time frame
1.To identify prevalence rate of diabetes in community for generating data. 2.To assess medication adherence in diabetic population in the community. 3.To assess knowledge about diabetes and anti-diabetic medications in the diabetes patients 4.To measure the self-care 5.To increase awareness about diabetes and the importance of treatment. 6.To render the education on diabetes in diabetic population about the diseases Timepoint: Day1 Day15 Day30	—

Measure

Time frame

1.To identify prevalence rate of diabetes in community for generating data. 2.To assess medication adherence in diabetic population in the community. 3.To assess knowledge about diabetes and anti-diabetic medications in the diabetes patients 4.To measure the self-care 5.To increase awareness about diabetes and the importance of treatment. 6.To render the education on diabetes in diabetic population about the diseases Timepoint: Day1 Day15 Day30

—

Secondary

Measure	Time frame
Economic BurdenTimepoint: Day1 Day15 Day30	—

Countries

India

Contacts

Public ContactShrikalp Deshpande

KBIPER K B Institute of Pharma Edu and Research

shrikalp@gmail.com07923245270

Outcome results